SALA, ANGELO
 Distribuzione geografica
Continente #
EU - Europa 10.424
NA - Nord America 8.262
AS - Asia 8.217
SA - Sud America 785
AF - Africa 153
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 5
Totale 27.878
Nazione #
US - Stati Uniti d'America 8.044
GB - Regno Unito 3.140
IT - Italia 3.015
SG - Singapore 2.509
CN - Cina 2.507
RU - Federazione Russa 904
DE - Germania 875
VN - Vietnam 700
HK - Hong Kong 699
SE - Svezia 592
BR - Brasile 579
TR - Turchia 422
FR - Francia 403
NL - Olanda 373
IN - India 334
KR - Corea 315
IE - Irlanda 263
FI - Finlandia 256
BD - Bangladesh 240
UA - Ucraina 173
CA - Canada 145
EU - Europa 138
ID - Indonesia 127
DK - Danimarca 96
JP - Giappone 92
AR - Argentina 58
CO - Colombia 54
GR - Grecia 53
CH - Svizzera 48
CI - Costa d'Avorio 47
PL - Polonia 42
MX - Messico 41
IQ - Iraq 38
ES - Italia 32
PH - Filippine 31
BE - Belgio 30
AT - Austria 28
AU - Australia 28
EC - Ecuador 27
RO - Romania 23
MY - Malesia 22
PK - Pakistan 22
ZA - Sudafrica 22
CL - Cile 18
SA - Arabia Saudita 18
UZ - Uzbekistan 18
IR - Iran 17
EG - Egitto 14
VE - Venezuela 14
MA - Marocco 13
TW - Taiwan 13
AL - Albania 12
IL - Israele 12
JO - Giordania 11
NO - Norvegia 11
NP - Nepal 11
PE - Perù 11
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
TN - Tunisia 10
KE - Kenya 9
KZ - Kazakistan 9
CZ - Repubblica Ceca 8
HR - Croazia 8
SC - Seychelles 8
BY - Bielorussia 6
DZ - Algeria 6
JM - Giamaica 5
LU - Lussemburgo 5
PT - Portogallo 5
TH - Thailandia 5
UY - Uruguay 5
AZ - Azerbaigian 4
BG - Bulgaria 4
BO - Bolivia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
LB - Libano 4
LT - Lituania 4
NZ - Nuova Zelanda 4
TT - Trinidad e Tobago 4
AM - Armenia 3
AO - Angola 3
CG - Congo 3
CY - Cipro 3
ET - Etiopia 3
HU - Ungheria 3
MD - Moldavia 3
OM - Oman 3
FK - Isole Falkland (Malvinas) 2
GT - Guatemala 2
HN - Honduras 2
KW - Kuwait 2
LY - Libia 2
MN - Mongolia 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
Totale 27.974
Città #
Southend 2.913
Singapore 1.366
Ashburn 764
Hong Kong 658
Milan 595
San Jose 571
Chandler 547
Seattle 534
Beijing 499
Wilmington 362
Princeton 353
Fairfield 316
Dallas 284
Santa Clara 281
Council Bluffs 268
Dublin 261
Ho Chi Minh City 240
Redmond 188
Rome 188
New York 166
Woodbridge 165
Ann Arbor 161
Hanoi 161
Lauterbourg 156
Munich 155
Houston 154
Los Angeles 152
Nanjing 147
Mountain View 145
Guangzhou 134
Buffalo 126
Dearborn 126
Sakarya 126
Bengaluru 117
Cambridge 117
Des Moines 110
Frankfurt am Main 109
Jacksonville 97
Shanghai 90
Toronto 89
Helsinki 87
Moscow 82
Boardman 79
Jinan 73
Jakarta 70
Tianjin 69
Grafing 68
São Paulo 64
Tokyo 60
Hefei 57
Shenyang 56
Phoenix 54
Redwood City 52
The Dalles 51
Columbus 50
Seoul 50
Padova 49
Abidjan 47
Berlin 47
Istanbul 46
Andover 44
Serra 44
Nanchang 43
Shenzhen 43
San Diego 41
Cangzhou 40
Hangzhou 40
Athens 39
Turin 39
Bogotá 37
Changsha 36
Eitensheim 35
Hebei 34
Naples 34
Catania 33
Verona 33
Fuzhou 30
London 30
Jiaxing 29
Warsaw 29
Chicago 28
Parma 28
Somerville 28
Da Nang 27
Palermo 27
Pavia 27
Saint Petersburg 27
Bitonto 26
Dong Ket 26
Zhengzhou 25
Cagliari 24
Sunnyvale 24
Wuhan 23
Bologna 22
Brussels 22
Haikou 22
Pune 22
Fremont 21
Haiphong 21
Medford 21
Totale 16.426
Nome #
English for pharmacy : biotechnologies, drugs, natural remedies and cosmetics 966
Droghe e farmaci psicoattivi 849
Stress ossidativo nella s. di Down : determinazione dell'8-isoprostano nell'esalato, nel siero e nelle urine 416
Proanthocyanidins from Vitis vinifera inhibit oxidative stress-induced vascular impairment in pulmonary arteries from diabetic rats 398
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 396
CHF6001 Inhibits NF-κB activation and neutrophilic recruitment in LPS-induced lung inflammation in mice 363
Lipid peroxidation and 5-lipoxygenase activity in chronic obstructive pulmonary disease 356
Arachidonic acid and docosahexaenoic acid metabolites in the airways of adults with cystic fibrosis: Effect of docosahexaenoic acid supplementation 323
5-Lipoxygenase activity, lipid peroxidation and the effect of antioxidant treatment in COPD subjects 292
Antiinflammatory and antioxidant effects of H2O2 generated by natural sources in Il1β-treated human endothelial cells 278
Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in Mice 275
Prostaglandin E2 possesses different potencies in inducing Vascular Endothelial Growth Factor and Interleukin-8 production in COPD human lung fibroblasts 273
Continuous wound infusion with chloroprocaine in a pig model of surgical lesion : Drug absorption and effects on inflammatory response 273
Beta2-adrenergic activity modulates vascular tone regulation in lecithin : cholesterol acyltransferase knockout mice 267
Synthesis of cysteinyl leukotrienes in human endothelial cells: subcellular localization and autocrine signaling through the CysLT2 receptor 259
Biomarkers of inflammation and oxidative stress in patients with COPD and healthy smokers 252
14, 15-Dehydroleukotriene A4: a specific substrate for leukotriene C4 synthase. 247
Biosintesi transcellulare degli eicosanoidi: un efficace sistema di bioamplificazione 247
Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells : Crucial role of 5-lipoxygenase 245
MicroRNA 143-145 deficiency impairs vascular function 243
Leukotriene E4 elimination and metabolism in normal human subjects 240
Bioactive Compounds in Edible Oils and Their Role in Oxidative Stress and Inflammation 240
Montelukast Use Decreases Cardiovascular Events in Asthmatics 239
Antagonism of thromboxane receptors by diclofenac and lumiracoxib 233
Azithromycin inhibits nuclear factor-κB activation during lung inflammation : an in vivo imaging study 232
Le basi farmacologiche della terapia 231
Blood fatty acids profile in mis-c children 227
Principi di farmacologia : classificazione, interazioni, indicazioni cliniche 226
Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: signaling through the CysLT2 receptor 226
Leukotriene synthesis and lipid peroxidation in COPD subjects 217
Rapid Metabolization of Protectin D1 by β-Oxidation of Its Polar Head Chain 215
Leukotriene B4 production in human mononuclear phagocytes is modulated by interleukin-4-induced 15-lipoxygenase 214
Le basi farmacologiche della terapia 210
Monoclonal anti-CD18 antibody prevents transcellular biosynthesis of cysteinyl leukotrienes in vitro and in vivo and protects against leukotriene-dependent increase in coronary vascular resistance and myocardial stiffness 209
The Atlas of Inflammation Resolution (AIR) 209
Le basi farmacologiche della terapia : il manuale 207
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain 206
Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations. 205
Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis 205
Monitoring inflammation and airway remodeling by fluorescence molecular tomography in a chronic asthma model 204
From field to health : a simple way to increase the nutraceutical content of grape ss shown by NO-Dependent vascular relaxation 201
Bioavailability of curcumin in the rat frontal lobe and hippocampus after repeated administration of MERIVA® 201
Droghe e farmaci psicoattivi 199
Role of sodium in intracellular calcium elevation and leukotriene B4 formation by agonist activated human neutrophils 198
Isoprostanes and oxidative stress in off-pump and on-pump coronary bypass surgery 196
Effects of mediterranean diet or low-fat diet on blood fatty acids in patients with coronary heart disease. A randomized intervention study 195
eNOS, COX-2, and prostacyclin production are impaired in endothelial cells from diabetics 192
beta2 Integrin-dependent neutrophil adhesion induced by minimally modified low-density lipoproteins is mainly mediated by F2-isoprostanes 192
A New Gateway for Rheumatoid Arthritis: COXIBs with an Improved Cardiovascular Profile 192
Farmaci per il sistema respiratorio 189
Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone 188
null 188
Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes. 185
Eosinophil 15-lipoxygenase is a leukotriene A4 synthase. 182
Principi di farmacologia : classificazione, interazioni, indicazioni cliniche 180
Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade 179
Bronchodilators Modulate Inflammation In Chronic Obstructive Pulmonary Disease Subjects 175
Nitric oxide modulation of transcellular biosynthesis of cys-leukotrienes in rabbit leukocyte-perfused heart 174
Cyclooxygenase-1 and prostacyclin production by endothelial cells in the presence of mild oxidative stress 173
A new class of nitric oxide-releasing derivatives of cetirizine; pharmacological profile in vascular and airway smooth muscle preparations 172
Negative ion tandem mass spectrometry of leukotriene E4 and LTE4 metabolites: Identification of LTE4 in human urine 172
CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration 170
Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends 169
Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype 168
Profile of COX-2 and PGI2 in human diabetic versus high glucose treated endothelial cells 168
Transcellular byosynthesis of eicosanoids 166
Transcellular biosynthesis of eicosanoid lipid mediators 166
Nonsteroidal Anti-Inflammatory Drugs: Exploiting Bivalent COXIB/ TP Antagonists for the Control of Cardiovascular Risk 166
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition 165
15 (S)-HETE modulates LTB4 production and neutrophil chemotaxis in chronic bronchitis 165
Dual COXIB/TP antagonists : a possible new twist in NSAID pharmacology and cardiovascular risk 164
Mediator release after endobronchial antigen challenge in patients with respiratory allergy 164
Muscarinic receptors, leukotriene B-4 production and neutrophilic inflammation in COPD patients 163
The pulmonary pharmacology of [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1, 3-benzenedicarboxamide](2NTX-99), an anti-atherotrombotic compound with therapeutic potential in pathological conditions that target lung vasculature 162
The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat 160
Treatment with natural anti-oxidants from vitis vinifera decreases lipid peroxidation in non insulin-dependent diabetics 156
Unsaturated fatty acids, omega-3 index and hospitalization in MISC 155
Exploratory study of the effect of DHA supplementation on blood fatty acids and inflammatory markers in children with MIS-C 155
Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients 154
Formation of sulphidopeptide-leukotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit. 153
Is the unbalance between arachidonic acid and docosahexaenoic acid a reversible condition in adults with cystic fibrosis? 152
Harnessing the translational power of bleomycin model: new insights to guide drug discovery for idiopathic pulmonary fibrosis 152
Citrus flavonoids effects on human umbilical vein 151
Pharmacological characterization of 2NTX-99, a potential antiatherothrombotic agent with antithromboxane and no-donor activity 150
Pharmacological modulation of the leukotriene pathway in allergic airway disease 149
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors 149
Mediators and allergic inflammation of human airways 149
Structural identification of cytochrome P450-dependent arachidonate metabolites formed by rabbit medullary thick ascending limb cells. 149
Estrogen receptor-alpha as a drug target candidate for preventing lung inflammation 147
Transcellular metabolism of leukotriene A4 by rabbit blood cells: lack of relevant LTC4-synthase activity in rabbit platelets. 147
Cysteinyl leukotrienes receptor activation in brain inflammatory reactions and oedema formation: a role for transcellular biosynthesis of cys-leukotrienes 147
IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases 147
Nasal neutrophilia and release of myeloperoxidase induced by nasal challenge with platelet activating factor: Different degrees of responsiveness in atopic and nonatopic subjects 146
15-Lipoxygenase expression and 15 (S)-hydroxyeicoisatetraenoic acid release and reincorporation in induced sputum of asthmatic subjects 144
EFFECTS OF LORATADINE ON CYTOSOLIC CA2+ LEVELS AND LEUKOTRIENE RELEASE - NOVEL MECHANISMS OF ACTION INDEPENDENT OF THE ANTIHISTAMINE ACTIVITY 143
Olive Phenol Hydroxytyrosol Prevents Passive Smoking--Induced Oxidative Stress 141
Endothelial-dependent dynamic and antithrombotic properties of porcine aortic and pulmonary valves 139
Antioxidant modulation of cyclooxygenase-2 in human bronchial smooth muscle cells 138
Myocardial protection by the leukotriene synthesis inhibitor BAY X1005: importance of transcellular biosynthesis of cysteinyl-leukotrienes. 137
Blood cell-vascular wall interactions and the production of coronary contracting sulfidopeptide leukotrienes in isolated, cell- perfused, rabbit heart 137
Totale 21.539
Categoria #
all - tutte 77.454
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.454


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021536 0 0 0 0 0 0 0 0 0 0 402 134
2021/20221.996 201 115 54 83 234 142 129 121 196 205 154 362
2022/20232.149 287 173 196 208 232 454 55 170 203 33 74 64
2023/20241.471 47 113 87 98 343 76 75 96 70 86 166 214
2024/20254.216 157 371 90 457 447 195 154 471 229 333 362 950
2025/20267.987 799 449 919 697 738 608 953 559 967 616 682 0
Totale 29.339